D. Lorenzen

780 total citations
20 papers, 650 citations indexed

About

D. Lorenzen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, D. Lorenzen has authored 20 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in D. Lorenzen's work include Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (4 papers) and Immune Cell Function and Interaction (4 papers). D. Lorenzen is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (4 papers) and Immune Cell Function and Interaction (4 papers). D. Lorenzen collaborates with scholars based in Germany, United States and Netherlands. D. Lorenzen's co-authors include Thomas F. Meyer, Hans‐Dieter Flad, Martin Ernst, Evelin Grage‐Griebenow, Christoph Dehio, Christian Wischke, Julian Zimmermann, Scott D. Gray‐Owen, Anja Haude and Hans‐Hubert Borchert and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Journal of Bacteriology.

In The Last Decade

D. Lorenzen

20 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Lorenzen Germany 12 321 186 162 114 78 20 650
Mauricio Urquiza Colombia 22 391 1.2× 168 0.9× 474 2.9× 107 0.9× 178 2.3× 52 1.2k
Elham Mohit Iran 17 206 0.6× 61 0.3× 402 2.5× 84 0.7× 101 1.3× 39 804
Jeffery A. Hobden United States 20 182 0.6× 67 0.4× 209 1.3× 36 0.3× 92 1.2× 29 829
Thomas Démoulins Switzerland 17 584 1.8× 52 0.3× 530 3.3× 121 1.1× 78 1.0× 31 948
Wafa Hanna Koury Cabrera Brazil 14 295 0.9× 32 0.2× 227 1.4× 56 0.5× 91 1.2× 52 681
Ryan J. Malonis United States 9 202 0.6× 63 0.3× 442 2.7× 69 0.6× 84 1.1× 12 657
L.M. Loomes United Kingdom 11 157 0.5× 111 0.6× 291 1.8× 36 0.3× 84 1.1× 14 573
Gabriel Morón Argentina 17 660 2.1× 28 0.2× 295 1.8× 120 1.1× 127 1.6× 37 998
Gabriele Köllisch Germany 10 457 1.4× 129 0.7× 166 1.0× 39 0.3× 80 1.0× 14 794
Thierry Lioux France 12 516 1.6× 41 0.2× 278 1.7× 68 0.6× 112 1.4× 16 681

Countries citing papers authored by D. Lorenzen

Since Specialization
Citations

This map shows the geographic impact of D. Lorenzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lorenzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lorenzen more than expected).

Fields of papers citing papers by D. Lorenzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lorenzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lorenzen. The network helps show where D. Lorenzen may publish in the future.

Co-authorship network of co-authors of D. Lorenzen

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lorenzen. A scholar is included among the top collaborators of D. Lorenzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lorenzen. D. Lorenzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorenzen, D., et al.. (2011). Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.. Journal of Clinical Oncology. 29(15_suppl). 2508–2508. 1 indexed citations
2.
Lorenzen, D., et al.. (2009). Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Journal of Clinical Oncology. 27(15_suppl). 3028–3028. 2 indexed citations
3.
Azémar, Marc, D. Lorenzen, Michael Huber, et al.. (2009). Tumour Biology: tumour-associated inflammation versus antitumor immunity.. PubMed. 29(11). 4795–805. 25 indexed citations
4.
Wischke, Christian, Julian Zimmermann, Bronson C. Wessinger, et al.. (2008). Poly(I:C) coated PLGA microparticles induce dendritic cell maturation. International Journal of Pharmaceutics. 365(1-2). 61–68. 71 indexed citations
5.
Hildenbrand, Bernd, D. Lorenzen, Barbara Sauer, et al.. (2008). IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.. PubMed. 28(3A). 1467–76. 7 indexed citations
6.
Neßelhut, T., Raymond Chang, Ingo Wilke, et al.. (2007). Dendritic cell therapy in glioblastoma multiforme. Journal of Clinical Oncology. 25(18_suppl). 3065–3065. 2 indexed citations
7.
Wischke, Christian, et al.. (2006). Stable cationic microparticles for enhanced model antigen delivery to dendritic cells. Journal of Controlled Release. 114(3). 359–368. 67 indexed citations
8.
Neßelhut, T., et al.. (2005). Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer. Journal of Clinical Oncology. 23(16_suppl). 2528–2528. 2 indexed citations
9.
Wischke, Christian, D. Lorenzen, Julian Zimmermann, & Gudrun H. Borchert. (2005). Preparation of protein loaded poly(d,l-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer. European Journal of Pharmaceutics and Biopharmaceutics. 62(3). 247–253. 15 indexed citations
10.
Neßelhut, T., Raymond Chang, D. Lorenzen, et al.. (2004). Cancer therapy with unloaded monocyte-derived dendritic cells in patients with inoperable pancreatic and gall bladder cancer. Journal of Clinical Oncology. 22(14_suppl). 2569–2569. 2 indexed citations
11.
Neßelhut, T., Raymond Chang, D. Lorenzen, et al.. (2004). Cancer therapy with unloaded monocyte-derived dendritic cells in patients with inoperable pancreatic and gall bladder cancer. Journal of Clinical Oncology. 22(14_suppl). 2569–2569. 2 indexed citations
12.
Stahl‐Hennig, Christiane, Nicole Stolte, N. Bischofberger, et al.. (2001). Enhanced Cellular Immune Response and Reduced CD8+ Lymphocyte Apoptosis in Acutely SIV-Infected Rhesus Macaques after Short-Term Antiretroviral Treatment. Virology. 279(1). 221–232. 26 indexed citations
13.
Hiller, Christian, Gültekin Tamgüney, Nicole Stolte, et al.. (2000). Herpesvirus Saimiri Pathogenicity Enhanced by Thymidine Kinase of Herpes Simplex Virus. Virology. 278(2). 445–455. 11 indexed citations
14.
Lorenzen, D., et al.. (2000). Neisseria gonorrhoeaePorin Modifies the Oxidative Burst of Human Professional Phagocytes. Infection and Immunity. 68(11). 6215–6222. 32 indexed citations
15.
Lorenzen, D., et al.. (2000). Neisseria gonorrhoeae Porin Modifies the Oxidative Burst of Human Professional Phagocytes. Infection and Immunity. 68(11). 6215–6222. 3 indexed citations
16.
Lorenzen, D., et al.. (1999). Immunoglobulin A1 Protease, an Exoenzyme of Pathogenic Neisseriae, Is a Potent Inducer of Proinflammatory Cytokines. The Journal of Experimental Medicine. 190(8). 1049–1058. 55 indexed citations
17.
18.
Gray‐Owen, Scott D., D. Lorenzen, Anja Haude, Thomas F. Meyer, & Christoph Dehio. (1997). Differential Opa specificities for CD66 receptors influence tissue interactions and cellular response to Neisseria gonorrhoeae. Molecular Microbiology. 26(5). 971–980. 132 indexed citations
19.
Lorenzen, D., et al.. (1997). An in vitro-differentiated human cell line as a model system to study the interaction of Neisseria gonorrhoeae with phagocytic cells. Infection and Immunity. 65(5). 1863–1869. 22 indexed citations
20.
Grage‐Griebenow, Evelin, et al.. (1993). Phenotypical and functional characterization of Fey receptor I (CD64)‐negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. European Journal of Immunology. 23(12). 3126–3135. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauricio Urquiza Breakdown of academic impact, for papers by Elham Mohit Breakdown of academic impact, for papers by Jeffery A. Hobden Breakdown of academic impact, for papers by Thomas Démoulins Breakdown of academic impact, for papers by Wafa Hanna Koury Cabrera Breakdown of academic impact, for papers by Ryan J. Malonis Breakdown of academic impact, for papers by L.M. Loomes Breakdown of academic impact, for papers by Gabriel Morón Breakdown of academic impact, for papers by Gabriele Köllisch Breakdown of academic impact, for papers by Thierry Lioux
Rankless by CCL
2026